PTCHF
Price
$1.67
Change
-$0.01 (-0.60%)
Updated
Jan 15 closing price
Capitalization
415.97M
STTK
Price
$1.11
Change
+$0.02 (+1.83%)
Updated
Jan 17 closing price
Capitalization
52.99M
58 days until earnings call
Ad is loading...

PTCHF vs STTK

Header iconPTCHF vs STTK Comparison
Open Charts PTCHF vs STTKBanner chart's image
PureTech Health
Price$1.67
Change-$0.01 (-0.60%)
Volume$322
Capitalization415.97M
Shattuck Labs
Price$1.11
Change+$0.02 (+1.83%)
Volume$117.31K
Capitalization52.99M
PTCHF vs STTK Comparison Chart
Loading...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTCHF vs. STTK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTCHF is a Hold and STTK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (PTCHF: $1.67 vs. STTK: $1.11)
Brand notoriety: PTCHF and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTCHF: 4% vs. STTK: 45%
Market capitalization -- PTCHF: $415.97M vs. STTK: $52.99M
PTCHF [@Biotechnology] is valued at $415.97M. STTK’s [@Biotechnology] market capitalization is $52.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCHF’s FA Score shows that 1 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • PTCHF’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, STTK is a better buy in the long-term than PTCHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTCHF’s TA Score shows that 4 TA indicator(s) are bullish while STTK’s TA Score has 3 bullish TA indicator(s).

  • PTCHF’s TA Score: 4 bullish, 3 bearish.
  • STTK’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both PTCHF and STTK are a good buy in the short-term.

Price Growth

PTCHF (@Biotechnology) experienced а -1.36% price change this week, while STTK (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

STTK is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($416M) has a higher market cap than STTK($53M). STTK YTD gains are higher at: -8.264 vs. PTCHF (-16.500). PTCHF has higher annual earnings (EBITDA): -53.65M vs. STTK (-76.01M). PTCHF has more cash in the bank: 502M vs. STTK (90.1M). STTK has less debt than PTCHF: STTK (3.62M) vs PTCHF (24M). STTK has higher revenues than PTCHF: STTK (6.44M) vs PTCHF (0).
PTCHFSTTKPTCHF / STTK
Capitalization416M53M785%
EBITDA-53.65M-76.01M71%
Gain YTD-16.500-8.264200%
P/E RatioN/AN/A-
Revenue06.44M-
Total Cash502M90.1M557%
Total Debt24M3.62M664%
FUNDAMENTALS RATINGS
PTCHF: Fundamental Ratings
PTCHF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTCHFSTTK
RSI
ODDS (%)
Bullish Trend 11 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
63%
Bearish Trend 11 days ago
82%
Momentum
ODDS (%)
Bullish Trend 11 days ago
66%
Bullish Trend 11 days ago
82%
MACD
ODDS (%)
Bearish Trend 11 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
68%
Bullish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
69%
Bearish Trend 11 days ago
88%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TACT4.510.03
+0.67%
TransAct Technologies
VVV36.22-0.26
-0.71%
Valvoline
CSX32.73-0.24
-0.73%
CSX Corp
TPVG7.61-0.12
-1.55%
TRIPLEPOINT VENTURE GROWTH BDC Corp
AVPT17.21-0.35
-1.99%
AvePoint

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and KURA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and KURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
KURA - PTCHF
30%
Poorly correlated
+1.11%
PRTC - PTCHF
30%
Poorly correlated
-3.26%
STTK - PTCHF
24%
Poorly correlated
+1.83%
LYEL - PTCHF
23%
Poorly correlated
+2.97%
BCTX - PTCHF
22%
Poorly correlated
-1.82%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
+1.83%
ACAD - STTK
39%
Loosely correlated
+0.29%
LSB - STTK
38%
Loosely correlated
+16.12%
VRTX - STTK
36%
Loosely correlated
+1.21%
ADCT - STTK
35%
Loosely correlated
+4.57%
GOSS - STTK
31%
Poorly correlated
-3.81%
More